CELLNEX TELECOM SA (472.DE) Fundamental Analysis & Valuation

FRA:472 • ES0105066007

Current stock price

26.45 EUR
+0.01 (+0.04%)
Last:

This 472.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. 472.DE Profitability Analysis

1.1 Basic Checks

  • 472 had negative earnings in the past year.
  • In the past year 472 had a positive cash flow from operations.
  • In the past 5 years 472 always reported negative net income.
  • 472 had a positive operating cash flow in each of the past 5 years.
472.DE Yearly Net Income VS EBIT VS OCF VS FCF472.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B

1.2 Ratios

  • With a Return On Assets value of -0.86%, 472 is not doing good in the industry: 70.97% of the companies in the same industry are doing better.
  • Looking at the Return On Equity, with a value of -2.98%, 472 is doing worse than 70.97% of the companies in the same industry.
  • 472's Return On Invested Capital of 0.65% is on the low side compared to the rest of the industry. 472 is outperformed by 74.19% of its industry peers.
  • 472 had an Average Return On Invested Capital over the past 3 years of 0.98%. This is significantly below the industry average of 7.19%.
Industry RankSector Rank
ROA -0.86%
ROE -2.98%
ROIC 0.65%
ROA(3y)-0.53%
ROA(5y)-0.63%
ROE(3y)-1.77%
ROE(5y)-1.99%
ROIC(3y)0.98%
ROIC(5y)0.72%
472.DE Yearly ROA, ROE, ROIC472.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2 -2 4 6 8

1.3 Margins

  • 472's Operating Margin of 7.46% is on the low side compared to the rest of the industry. 472 is outperformed by 67.74% of its industry peers.
  • In the last couple of years the Operating Margin of 472 has grown nicely.
  • 472 does not have Profit Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM 7.46%
PM (TTM) N/A
GM N/A
OM growth 3Y28.21%
OM growth 5Y5.67%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
472.DE Yearly Profit, Operating, Gross Margins472.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. 472.DE Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so 472 is destroying value.
  • The number of shares outstanding for 472 has been reduced compared to 1 year ago.
  • 472 has more shares outstanding than it did 5 years ago.
  • 472 has a worse debt/assets ratio than last year.
472.DE Yearly Shares Outstanding472.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M
472.DE Yearly Total Debt VS Total Assets472.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B

2.2 Solvency

  • 472 has an Altman-Z score of 0.35. This is a bad value and indicates that 472 is not financially healthy and even has some risk of bankruptcy.
  • 472 has a worse Altman-Z score (0.35) than 67.74% of its industry peers.
  • 472 has a debt to FCF ratio of 41.63. This is a negative value and a sign of low solvency as 472 would need 41.63 years to pay back of all of its debts.
  • 472 has a worse Debt to FCF ratio (41.63) than 67.74% of its industry peers.
  • A Debt/Equity ratio of 1.58 is on the high side and indicates that 472 has dependencies on debt financing.
  • 472's Debt to Equity ratio of 1.58 is on the low side compared to the rest of the industry. 472 is outperformed by 74.19% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.58
Debt/FCF 41.63
Altman-Z 0.35
ROIC/WACC0.13
WACC5.04%
472.DE Yearly LT Debt VS Equity VS FCF472.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B 15B 20B

2.3 Liquidity

  • 472 has a Current Ratio of 0.51. This is a bad value and indicates that 472 is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 0.51, 472 is doing worse than 83.87% of the companies in the same industry.
  • A Quick Ratio of 0.50 indicates that 472 may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.50, 472 is doing worse than 83.87% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.51
Quick Ratio 0.5
472.DE Yearly Current Assets VS Current Liabilites472.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. 472.DE Growth Analysis

3.1 Past

  • The earnings per share for 472 have decreased strongly by -147.68% in the last year.
  • Looking at the last year, 472 shows a small growth in Revenue. The Revenue has grown by 6.18% in the last year.
  • The Revenue has been growing by 23.11% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-147.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-108.85%
Revenue 1Y (TTM)6.18%
Revenue growth 3Y8.13%
Revenue growth 5Y23.11%
Sales Q2Q%-18.41%

3.2 Future

  • The Earnings Per Share is expected to grow by 34.67% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, 472 will show a small growth in Revenue. The Revenue will grow by 5.09% on average per year.
EPS Next Y121.31%
EPS Next 2Y59.24%
EPS Next 3Y44.44%
EPS Next 5Y34.67%
Revenue Next Year3.74%
Revenue Next 2Y3.97%
Revenue Next 3Y3.28%
Revenue Next 5Y5.09%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
472.DE Yearly Revenue VS Estimates472.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B
472.DE Yearly EPS VS Estimates472.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 0.5 1

More info and screens

Find the best growth stocksShow best growing peers

1

4. 472.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • 472 reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Based on the Price/Forward Earnings ratio of 318.29, the valuation of 472 can be described as expensive.
  • 472's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. 472 is more expensive than 77.42% of the companies in the same industry.
  • 472's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.19.
Industry RankSector Rank
PE N/A
Fwd PE 318.29
472.DE Price Earnings VS Forward Price Earnings472.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 100 200 300

4.2 Price Multiples

  • 74.19% of the companies in the same industry are cheaper than 472, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, 472 is valued a bit more expensive than the industry average as 67.74% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 34.33
EV/EBITDA 12.74
472.DE Per share data472.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates 472 does not grow enough to justify the current Price/Earnings ratio.
  • 472's earnings are expected to grow with 44.44% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y59.24%
EPS Next 3Y44.44%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

2

5. 472.DE Dividend Analysis

5.1 Amount

  • 472 has a Yearly Dividend Yield of 1.65%. Purely for dividend investing, there may be better candidates out there.
  • Compared to an average industry Dividend Yield of 3.12, 472 has a dividend in line with its industry peers.
  • 472's Dividend Yield is comparable with the S&P500 average which is at 1.89.
Industry RankSector Rank
Dividend Yield 1.65%

5.2 History

Dividend Growth(5Y)N/A
Div Incr YearsN/A
Div Non Decr YearsN/A

5.3 Sustainability

  • 472 has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-3.28%
EPS Next 2Y59.24%
EPS Next 3Y44.44%
472.DE Yearly Income VS Free CF VS Dividend472.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M -400M -600M

More info and screens

Find the best dividend stocksShow peers with best dividend

472.DE Fundamentals: All Metrics, Ratios and Statistics

CELLNEX TELECOM SA

FRA:472 (3/27/2026, 7:00:00 PM)

26.45

+0.01 (+0.04%)

Chartmill FA Rating
GICS IndustryGroupTelecommunication Services
GICS IndustryDiversified Telecommunication Services
Earnings (Last)02-27
Earnings (Next)04-30
Inst Owners67.58%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap18.05B
Revenue(TTM)4.62B
Net Income(TTM)-360.82M
Analysts78.89
Price Target39 (47.45%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.65%
Yearly Dividend0.02
Dividend Growth(5Y)N/A
DP-3.28%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-227.93%
Min EPS beat(2)-301.69%
Max EPS beat(2)-154.16%
EPS beat(4)1
Avg EPS beat(4)-120.86%
Min EPS beat(4)-301.69%
Max EPS beat(4)31.37%
EPS beat(8)4
Avg EPS beat(8)608.7%
EPS beat(12)6
Avg EPS beat(12)403.79%
EPS beat(16)7
Avg EPS beat(16)301.05%
Revenue beat(2)2
Avg Revenue beat(2)4.84%
Min Revenue beat(2)3.18%
Max Revenue beat(2)6.5%
Revenue beat(4)3
Avg Revenue beat(4)1.75%
Min Revenue beat(4)-6.04%
Max Revenue beat(4)6.5%
Revenue beat(8)5
Avg Revenue beat(8)2.44%
Revenue beat(12)8
Avg Revenue beat(12)4.65%
Revenue beat(16)9
Avg Revenue beat(16)3.6%
PT rev (1m)0%
PT rev (3m)-3.94%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-55.75%
EPS NY rev (3m)-50.02%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-1.17%
Revenue NY rev (3m)-1.36%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 318.29
P/S 3.9
P/FCF 34.33
P/OCF 7.9
P/B 1.49
P/tB N/A
EV/EBITDA 12.74
EPS(TTM)-0.39
EYN/A
EPS(NY)0.08
Fwd EY0.31%
FCF(TTM)0.77
FCFY2.91%
OCF(TTM)3.35
OCFY12.67%
SpS6.78
BVpS17.76
TBVpS-13.99
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -0.86%
ROE -2.98%
ROCE 0.93%
ROIC 0.65%
ROICexc 0.68%
ROICexgc 1.74%
OM 7.46%
PM (TTM) N/A
GM N/A
FCFM 11.37%
ROA(3y)-0.53%
ROA(5y)-0.63%
ROE(3y)-1.77%
ROE(5y)-1.99%
ROIC(3y)0.98%
ROIC(5y)0.72%
ROICexc(3y)1.01%
ROICexc(5y)0.75%
ROICexgc(3y)2.57%
ROICexgc(5y)1.98%
ROCE(3y)1.39%
ROCE(5y)1.03%
ROICexgc growth 3Y38.81%
ROICexgc growth 5Y11.38%
ROICexc growth 3Y44.88%
ROICexc growth 5Y13.97%
OM growth 3Y28.21%
OM growth 5Y5.67%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.11
Health
Industry RankSector Rank
Debt/Equity 1.58
Debt/FCF 41.63
Debt/EBITDA 6.36
Cap/Depr 65.85%
Cap/Sales 38.07%
Interest Coverage 0.45
Cash Conversion 75.76%
Profit Quality N/A
Current Ratio 0.51
Quick Ratio 0.5
Altman-Z 0.35
F-Score4
WACC5.04%
ROIC/WACC0.13
Cap/Depr(3y)75.82%
Cap/Depr(5y)85.3%
Cap/Sales(3y)46.89%
Cap/Sales(5y)54.84%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-147.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-108.85%
EPS Next Y121.31%
EPS Next 2Y59.24%
EPS Next 3Y44.44%
EPS Next 5Y34.67%
Revenue 1Y (TTM)6.18%
Revenue growth 3Y8.13%
Revenue growth 5Y23.11%
Sales Q2Q%-18.41%
Revenue Next Year3.74%
Revenue Next 2Y3.97%
Revenue Next 3Y3.28%
Revenue Next 5Y5.09%
EBIT growth 1Y-61.55%
EBIT growth 3Y38.62%
EBIT growth 5Y30.1%
EBIT Next Year465.65%
EBIT Next 3Y83.82%
EBIT Next 5Y46.95%
FCF growth 1Y90.35%
FCF growth 3YN/A
FCF growth 5Y76.58%
OCF growth 1Y-0.89%
OCF growth 3Y7.72%
OCF growth 5Y23.67%

CELLNEX TELECOM SA / 472.DE Fundamental Analysis FAQ

What is the ChartMill fundamental rating of CELLNEX TELECOM SA (472.DE) stock?

ChartMill assigns a fundamental rating of 2 / 10 to 472.DE.


What is the valuation status for 472 stock?

ChartMill assigns a valuation rating of 1 / 10 to CELLNEX TELECOM SA (472.DE). This can be considered as Overvalued.


How profitable is CELLNEX TELECOM SA (472.DE) stock?

CELLNEX TELECOM SA (472.DE) has a profitability rating of 2 / 10.


What is the earnings growth outlook for CELLNEX TELECOM SA?

The Earnings per Share (EPS) of CELLNEX TELECOM SA (472.DE) is expected to grow by 121.31% in the next year.


Can you provide the dividend sustainability for 472 stock?

The dividend rating of CELLNEX TELECOM SA (472.DE) is 2 / 10 and the dividend payout ratio is -3.28%.